RIFATER

Rifater Adverse Events Reported to the FDA Over Time

How are Rifater adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Rifater, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Rifater is flagged as the suspect drug causing the adverse event.

Most Common Rifater Adverse Events Reported to the FDA

What are the most common Rifater adverse events reported to the FDA?

Immune Reconstitution Syndrome	32 (3.41%)
Pyrexia	31 (3.3%)
Cytolytic Hepatitis	24 (2.56%)
Drug Rash With Eosinophilia And Sys...	19 (2.02%)
Eosinophilia	17 (1.81%)
Impaired Gastric Emptying	17 (1.81%)
Renal Failure	17 (1.81%)
Lymphadenopathy	16 (1.7%)
Renal Failure Acute	14 (1.49%)
Alanine Aminotransferase Increased	13 (1.38%)
Hepatic Failure	13 (1.38%)
	Show More
Liver Function Test Abnormal	13 (1.38%)
Nausea	12 (1.28%)
Neuropathy Peripheral	12 (1.28%)
Proteinuria	12 (1.28%)
Cholestasis	11 (1.17%)
Aspartate Aminotransferase Increase...	10 (1.06%)
Rash	10 (1.06%)
Vomiting	10 (1.06%)
Anaemia	9 (.96%)
Colour Blindness	9 (.96%)
Oedema Peripheral	9 (.96%)
Agranulocytosis	8 (.85%)
Blood Alkaline Phosphatase Increase...	8 (.85%)
General Physical Health Deteriorati...	8 (.85%)
Hepatitis	8 (.85%)
Hyperbilirubinaemia	8 (.85%)
Hypomagnesaemia	8 (.85%)
Asthenia	7 (.75%)
Drug Ineffective	7 (.75%)
Liver Disorder	7 (.75%)
Thrombocytopenia	7 (.75%)
Transaminases Increased	7 (.75%)
Tuberculosis	7 (.75%)
Abdominal Pain	6 (.64%)
Acidosis	6 (.64%)
Convulsion	6 (.64%)
Death	6 (.64%)
Drug Exposure During Pregnancy	6 (.64%)
Dyspnoea	6 (.64%)
Lipase Increased	6 (.64%)
Multi-organ Failure	6 (.64%)
Neutropenia	6 (.64%)
Pancreatitis	6 (.64%)
Pancytopenia	6 (.64%)
Stevens-johnson Syndrome	6 (.64%)
Toxic Skin Eruption	6 (.64%)
Blood Bilirubin Increased	5 (.53%)
Confusional State	5 (.53%)
Epilepsy	5 (.53%)
Hypertension	5 (.53%)
Hypoalbuminaemia	5 (.53%)
Jaundice	5 (.53%)
Malaise	5 (.53%)
Pruritus	5 (.53%)
Weight Decreased	5 (.53%)
Abortion Spontaneous	4 (.43%)
Blood Creatine Phosphokinase Increa...	4 (.43%)
Erythema	4 (.43%)
Extrapyramidal Disorder	4 (.43%)
Haemorrhage	4 (.43%)
Headache	4 (.43%)
Hepatitis Fulminant	4 (.43%)
Hepatomegaly	4 (.43%)
Rash Maculo-papular	4 (.43%)
Systemic Inflammatory Response Synd...	4 (.43%)
Activities Of Daily Living Impaired	3 (.32%)
Anorexia	3 (.32%)
Anuria	3 (.32%)
Arthritis Fungal	3 (.32%)
Blood Amylase Increased	3 (.32%)
Bone Marrow Failure	3 (.32%)
Coma Hepatic	3 (.32%)
Condition Aggravated	3 (.32%)
Decreased Appetite	3 (.32%)
Delirium	3 (.32%)
Disease Progression	3 (.32%)
Drug Interaction	3 (.32%)
Encephalitis	3 (.32%)
Haematoma	3 (.32%)
Hepatic Enzyme Increased	3 (.32%)
Hepatocellular Injury	3 (.32%)
Hyperthermia	3 (.32%)
Hyperuricaemia	3 (.32%)
Hypoglycaemia	3 (.32%)
Inflammation	3 (.32%)
Mixed Liver Injury	3 (.32%)
Petechiae	3 (.32%)
Pleural Neoplasm	3 (.32%)
Psychotic Disorder	3 (.32%)
Tongue Haemorrhage	3 (.32%)
Vasculitis	3 (.32%)
Acute Hepatic Failure	2 (.21%)
Acute Respiratory Distress Syndrome	2 (.21%)
Anaemia Haemolytic Autoimmune	2 (.21%)
Aplasia	2 (.21%)
Bacterial Infection	2 (.21%)
Bicytopenia	2 (.21%)
Blister	2 (.21%)
C-reactive Protein Increased	2 (.21%)
Caesarean Section	2 (.21%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Rifater, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Rifater is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Rifater

What are the most common Rifater adverse events reported to the FDA?

Hepatic And Hepatobiliary	103 (10.97%)
Epidermal And Dermal Conditions	75 (7.99%)
Hepatobiliary	53 (5.64%)
Renal Disorders	35 (3.73%)
White Blood Cell	35 (3.73%)
Body Temperature Conditions	34 (3.62%)
Immunodeficiency Syndromes	32 (3.41%)
Gastrointestinal Signs	30 (3.19%)
Anemias Nonhemolytic And Marrow Dep...	20 (2.13%)
Spleen, Lymphatic And Reticulendoth...	20 (2.13%)
Gastrointestinal Motility And Defec...	18 (1.92%)
	Show More
Enzyme	14 (1.49%)
Neurological	14 (1.49%)
Infections - Pathogen Unspecified	13 (1.38%)
Seizures	13 (1.38%)
Mycobacterial Infectious	12 (1.28%)
Peripheral Neuropathies	12 (1.28%)
Urinary Tract Signs	12 (1.28%)
Respiratory	11 (1.17%)
Exocrine Pancreas Conditions	10 (1.06%)
Platelet	10 (1.06%)
Therapeutic And Nontherapeutic Effe...	10 (1.06%)
Acid-base	9 (.96%)
Eye Disorders Congenital	9 (.96%)
Fungal Infectious	9 (.96%)
Gastrointestinal	9 (.96%)
Hematology Investigations	9 (.96%)
Bone, Calcium, Magnesium And Phosph...	8 (.85%)
Deliria	8 (.85%)
Movement Disorders	8 (.85%)
Oral Soft Tissue Conditions	8 (.85%)
Appetite And General Nutritional	7 (.75%)
Chemical Injury And Poisoning	7 (.75%)
Physical Examination Topics	7 (.75%)
Vascular Hemorrhagic	7 (.75%)
Bacterial Infectious	6 (.64%)
Disturbances In Thinking	6 (.64%)
Fatal Outcomes	6 (.64%)
Joint	6 (.64%)
Skin Vascular Abnormalities	6 (.64%)
Cardiac Arrhythmias	5 (.53%)
Central Nervous System Infections A...	5 (.53%)
Lifestyle Issues	5 (.53%)
Protein And Amino Acid Metabolism	5 (.53%)
Vascular Hypertensive	5 (.53%)
Abortions And Stillbirth	4 (.43%)
Allergic Conditions	4 (.43%)
Decreased And Nonspecific Blood Pre...	4 (.43%)
Glucose Metabolism Disorders	4 (.43%)
Headaches	4 (.43%)
Hemolyses And Related Conditions	4 (.43%)
Metabolic And Nutritional Disorders...	4 (.43%)
Muscle	4 (.43%)
Respiratory And Mediastinal Neoplas...	4 (.43%)
Toxicology And Therapeutic Drug Mon...	4 (.43%)
Central Nervous System Vascular	3 (.32%)
Cranial Nerve Disorders	3 (.32%)
Embolism And Thrombosis	3 (.32%)
Lower Respiratory Tract Disorders	3 (.32%)
Metabolic, Nutritional And Blood Ga...	3 (.32%)
Microbiology And Serology	3 (.32%)
Obstetric And Gynecological Therape...	3 (.32%)
Purine And Pyrimidine Metabolism	3 (.32%)
Schizophrenia And Other Psychotic	3 (.32%)
Tongue Conditions	3 (.32%)
Vascular Inflammations	3 (.32%)
Viral Infectious	3 (.32%)
Bronchial Disorders	2 (.21%)
Congenital And Hereditary	2 (.21%)
Depressed Mood Disorders	2 (.21%)
Gallbladder	2 (.21%)
Gastrointestinal Hemorrhages	2 (.21%)
Gastrointestinal Inflammatory Condi...	2 (.21%)
Hematopoietic Neoplasms	2 (.21%)
Medication Errors	2 (.21%)
Nephropathies	2 (.21%)
Neuromuscular	2 (.21%)
Placental, Amniotic And Cavity Diso...	2 (.21%)
Pleural	2 (.21%)
Pregnancy, Labour, Delivery And Pos...	2 (.21%)
Protein And Chemistry Analyses	2 (.21%)
Pulmonary Vascular	2 (.21%)
Upper Respiratory Tract Disorders	2 (.21%)
Vascular	2 (.21%)
Vision	2 (.21%)
Angiedema And Urticaria	1 (.11%)
Anxiety Disorders	1 (.11%)
Cardiac And Vascular Investigations	1 (.11%)
Changes In Physical Activity	1 (.11%)
Connective Tissue Disorders	1 (.11%)
Cornification And Dystrophic Skin	1 (.11%)
Electrolyte And Fluid Balance Condi...	1 (.11%)
Encephalopathies	1 (.11%)
Fetal And Neonatal	1 (.11%)
Food Intolerance Syndromes	1 (.11%)
Hearing	1 (.11%)
Hematological And Lymphoid Tissue T...	1 (.11%)
Hepatobiliary Therapeutic Procedure...	1 (.11%)
Immune	1 (.11%)
Lipid Analyses	1 (.11%)
Lymphomas	1 (.11%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Rifater, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Rifater is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.